Literature DB >> 20961890

Cystatin C, mortality risk and clinical triage in US adults: threshold values and hierarchical importance.

Robert N Foley1, Changchun Wang, Allan J Collins.   

Abstract

BACKGROUND: It has been suggested that cystatin C may be a superior measure of estimated glomerular filtration rate (eGFR) than creatinine-based methods. We aimed to assess the utility of cystatin C for clinical triage in community-based settings.
METHODS: We identified cystatin C thresholds that maximize sensitivity and specificity (Max(Sn + Sp)) for predicting death and subsequently applied classification tree methodology considering serum creatinine, creatinine-based eGFR, urinary albumin-creatinine ratio and conventional modifiable risk factors to define subgroups, interactions and hierarchical ranks in fasting US adults (National Health and Nutrition Examination Survey 1988-94, followed through 2006).
RESULTS: A threshold cystatin C value of 0.94 mg/L exhibited the best maximum combined value of sensitivity and specificity for predicting death (Max(Sn + Sp), Sn 0.64/Sp 0.78). When all variables were considered jointly in a classification tree, cystatin C and albumin-creatinine ratio were the primary mortality discriminators in subgroups that added up to 41 and 14% of the study population, respectively; serum creatinine and creatinine-based eGFR were non-discriminatory.
CONCLUSION: Cystatin C may be useful for risk-based clinical triage in public health settings.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961890      PMCID: PMC3145398          DOI: 10.1093/ndt/gfq629

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  37 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Calculation of glomerular filtration rate expressed in mL/min from plasma cystatin C values in mg/L.

Authors:  A Larsson; J Malm; A Grubb; L O Hansson
Journal:  Scand J Clin Lab Invest       Date:  2004       Impact factor: 1.713

3.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

4.  Cystatin C concentration as a risk factor for heart failure in older adults.

Authors:  Mark J Sarnak; Ronit Katz; Catherine O Stehman-Breen; Linda F Fried; Nancy Swords Jenny; Bruce M Psaty; Anne B Newman; David Siscovick; Michael G Shlipak
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

5.  Cystatin C and the risk of death and cardiovascular events among elderly persons.

Authors:  Michael G Shlipak; Mark J Sarnak; Ronit Katz; Linda F Fried; Stephen L Seliger; Anne B Newman; David S Siscovick; Catherine Stehman-Breen
Journal:  N Engl J Med       Date:  2005-05-19       Impact factor: 91.245

6.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.

Authors:  Robert N Foley; Anne M Murray; Shuling Li; Charles A Herzog; A Marshall McBean; Paul W Eggers; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2004-12-08       Impact factor: 10.121

7.  Cystatin C and subclinical brain infarction.

Authors:  Stephen L Seliger; W T Longstreth; Ronit Katz; Teri Manolio; Linda F Fried; Michael Shlipak; Catherine O Stehman-Breen; Anne Newman; Mark Sarnak; Daniel L Gillen; Anthony Bleyer; David S Siscovick
Journal:  J Am Soc Nephrol       Date:  2005-10-19       Impact factor: 10.121

8.  A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate.

Authors:  Frans J Hoek; Frits A W Kemperman; Raymond T Krediet
Journal:  Nephrol Dial Transplant       Date:  2003-10       Impact factor: 5.992

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

10.  Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate.

Authors:  A Grubb; O Simonsen; G Sturfelt; L Truedsson; H Thysell
Journal:  Acta Med Scand       Date:  1985
View more
  2 in total

1.  Kidney Function After the First Kidney Stone Event.

Authors:  William E Haley; Felicity T Enders; Lisa E Vaughan; Ramila A Mehta; Maxton E Thoman; Terri J Vrtiska; Amy E Krambeck; John C Lieske; Andrew D Rule
Journal:  Mayo Clin Proc       Date:  2016-10-21       Impact factor: 7.616

2.  Higher Cystatin C Levels Are Associated With Neurocognitive Impairment in Older HIV+ Adults.

Authors:  Marissa E Sakoda; Pariya L Fazeli; Ronald J Ellis; Dilip V Jeste; Igor Grant; Scott L Letendre; David J Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2017-03-01       Impact factor: 3.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.